University of Minnesota. Driven to Discover.
A 3-track system would offer key advantages to the FDA's approach, the experts say.
Rates of prevention of recurrent C diff were similar, with fewer side effects.
The data show emergency department visits, among other factors, increase C difficile risk.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.